Showing results (1-10 of 291) with videos related to
Sort By:
Pageof 30
Current Opinion in Molecular Therapeutics|March 16, 2001
Retroviral vector-mediated gene expression in hematopoietic cellsC Baum, A Richters, W OstertagMolecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
CD34 splice variant: an attractive marker for selection of gene-modified cellsB Fehse, A Richters, K Putimtseva-Scharf, et al.Acta Haematologica|May 20, 1998
cis-Active elements of Friend spleen focus-forming virus: from disease induction to disease preventionC Baum, N Hunt, M Hildinger, et al.Journal of Virology|April 10, 1999
Design of 5' untranslated sequences in retroviral vectors developed for medical useM Hildinger, K L Abel, W Ostertag, et al.Experimental Hematology|February 1, 1996
Activity of Friend mink cell focus-forming retrovirus during myelo-erythroid hematopoiesisC Baum, H G Eckert, C Stocking, et al.Journal of Virology|September 1, 1997
The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBFC Baum, K Itoh, J Meyer, et al.Gene Therapy|June 23, 2001
Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategyH Klump, B Schiedlmeier, B Vogt, et al.Journal of Virology|December 1, 1995
Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cellsC Baum, S Hegewisch-Becker, H G Eckert, et al.Gene Therapy|February 4, 1999
FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cellsM Hildinger, H G Eckert, A J Schilz, et al.Human Gene Therapy|February 11, 1998
Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectorsM Hildinger, B Fehse, S Hegewisch-Becker, et al.Pageof 30